| 1 |
35386439 | Glucose and MMP-9 dual-responsive hydrogel with temperature sensitive self-adaptive shape and controlled drug release accelerates diabetic wound healing. | 2022 Nov |
2 |
| 2 |
31629465 | A novel celecoxib analog UTX-121 inhibits HT1080 cell invasion by modulating membrane-type 1 matrix metalloproteinase. | 2020 Jan 1 |
1 |
| 3 |
32792943 | Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells. | 2020 |
1 |
| 4 |
32994805 | Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity. | 2020 |
1 |
| 5 |
33019464 | The molecular mechanisms of celecoxib in tumor development. | 2020 Oct 2 |
1 |
| 6 |
33194674 | Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. | 2020 |
1 |
| 7 |
29383179 | Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer. | 2017 Dec 29 |
1 |
| 8 |
27430377 | Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells. | 2016 Sep |
1 |
| 9 |
26592832 | Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line. | 2015 Nov |
4 |
| 10 |
24640603 | Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity. | 2014 Feb |
1 |
| 11 |
24721459 | Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress. | 2014 Jun |
1 |
| 12 |
19715751 | Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. | 2009 Nov 12 |
1 |
| 13 |
18303430 | Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. | 2008 Feb |
1 |
| 14 |
17404023 | The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. | 2007 Jan |
2 |
| 15 |
17313803 | [The inhibitive effects of celecoxib combined with octreotide on the metastasis of human gastric cancer in vivo]. | 2006 Dec 12 |
1 |
| 16 |
16190383 | [Significance and expression of cyclooxygenase-2 mRNA in peripheral blood monocytes in patients with acute coronary syndrome]. | 2005 Aug |
1 |
| 17 |
16253161 | [The role of hypoxia on expression of cyclooxygenase-2 in synovial fibroblasts derived from human temporomandular joint]. | 2005 Jul 6 |
1 |
| 18 |
15256475 | Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. | 2004 Jul 15 |
1 |